Similarly, studies that tested the effects of NLRP3 inhibition for the treatment of chemotherapy‐induced neuropathy failed to assess these effects in tumor‐bearing animals.9, 14, 15, 16. The gene discussed is NLRP3; the disease is neuropathy.